ReviewRespiratory research2024
Tezepelumab for severe asthma: elevating current practice to recognize epithelial driven profiles.
Marco Caminati et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it